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BACKGROUND
The potential of forced spirometry (FS) testing for diagnosis,
monitoring and management of chronic respiratory patients is
well established1–3 such that FS is a pivotal test in both respiratory
medicine and primary care. Moreover, it also shows potential
in the informal care scenario: that is, in pharmacy ofﬁces for
case-ﬁnding purposes4,5 and for self-management in selected
patients.6,7
We acknowledge that well-designed studies8 have failed to
show practical beneﬁts of FS for asthma and COPD diagnosis and
management in primary care. However, it has been demonstrated
that historical limitations for extensive use of FS in primary care,
because of suboptimal quality of testing, can be overcome by off-
line remote support by specialised professionals.9,10 Large-scale
deployment of this type of setting has generated evidence of
cost-effectiveness.11,12
All the above elements13,14 allow us to identify and
develop9,15–18 the four pivotal components needed for regional
deployment in Catalonia (ES; 7.5 million inhabitants) of a
collaborative FS program across health-care tiers. The four core
components of the FS program are illustrated in Figure 1.
The underlying hypothesis is that the proposed FS program
facilitates the transference of diagnostic testing from specialised
care to non-specialised primary care professionals, which may
generate signiﬁcant health-care efﬁciencies and provide valuable
information on longitudinal changes of lung function either
spontaneously or because of interventions.
The current protocol describes the roadmap for scale-up of the
Catalan collaborative FS program based on the existing regional
interoperability setting among health-care providers, which
has two principal components, namely, (i) the regional shared
electronic health-care record19 allowing health information
exchange among providers, and (ii) the personal health folder20
that facilitates citizen's accessibility to his/her health-care
information.
AIMS
The current protocol describes the elements for the deployment
of an innovative collaborative FS testing program across
health-care tiers in Catalonia. The roadmap for deployment
of the FS program has three well-deﬁned actions. The ﬁrst is
implementation of the program in three health-care sectors
during the ﬁrst semester of 2016. Thereafter, deployment of the
program throughout the entire Catalan region will be completed
by the end of the year. Third, the research is paying speciﬁc
attention to two distinctive transferability aspects: that is,
adaptability of the FS program to sites having different intero-
perability schemes or no interoperability at all, and generalisation
of this type of program to other respiratory (i.e., home-based sleep
studies) and non-respiratory (i.e., electrocardiogram) testing
modalities. Moreover, the deployment process of the FS program
will also cover the needs for data analytics allowing longitudinal
assessment of lung function changes with relevant implications in
future personalised patient management.21
METHODS
The FS program emerges from a series of studies reporting on
technological solutions for each of the main components
illustrated in Figure 1.9,16–18 Their articulated application covers
unmet needs for collaborative FS testing. The studies were
initiated within the EU project NEXES,22,23 and speciﬁc parts of the
overall setting have already been successfully evaluated in the
Basque Country.11,12
The setting and study design
The current protocol has been designed as part of the regional
deployment of integrated care services in Catalonia.22,23 It consists
of the two lines of activity ultimately aiming at (i) regional
adoption of the FS program and (ii) generalisation of the approach
to other areas, as well as to other testing procedures (i.e.,
home-based sleep studies, electrocardiogram and so on). The
research was approved by the Ethical Committee of the Hospital
Clínic de Barcelona, and it has been registered at ClinicalTrials.gov
Id: NCT02592928.
Program deployment
During the initial 6 months, the protocol will include three health-
care sectors: Lleida (366k inhabitants and 22 Primary Care Centers,
PCC), Vic (157k inhabitants and 11 PCC) and Atenció Integral en
Salut Barcelona-Esquerra (520k inhabitants and 19 PCC, respec-
tively) following a Plan-Do-Study-Act (PDSA) methodology.24 The
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main purpose of the ﬁrst PDSA cycle (January–March 2016)
including a total of three PCC, one in each health-care sector,
is to ensure full functionality of the setting (Figure 1). Immediately
thereafter, the FS program will be progressively deployed to
all 52 PCC in the three health-care sectors in a second 3-month
PDSA cycle that will be completed by mid-2016. FS testing
will be prescribed by the attending general practitioner following
standard criteria, and it will be carried out by primary care
nurses.
The deployment of the program to the entire region (369 PCC)
will be completed, with no discontinuation, within 2016. The
outcomes of the assessment carried out during each PDSA cycle
will contribute to identify key performance indicators (KPI) that are
helpful in modulating the long-term assessment strategy of the FS
program beyond the deployment phase.
Transferability and data analytics
A relevant line of activity will be devoted to analysis of
transferability and proposals for data analytics to be completed
in parallel with deployment of the FS program. The transferability
analysis will encompass two distinctive areas: (i) identiﬁcation
of deployment strategies for regions with limited or no inter-
operability architecture at regional level, and (ii) evaluation of the
potential for transferring the characteristics of the program to
other testing procedures, such as home-based sleep studies
and/or electrocardiogram.
Service workﬂow and ICT support
The section describes the technological support required to cover
the four components of the FS program, as depicted in Figure 1:
(i) enhanced automatic FS quality assessment; (ii) accessibility
to standardised (and quality-labelled) FS testing information
across health-care tiers; (iii) generation of an individual FS report
including historical results from a given patient; and (iv) clinical
decision support systems in the clinical workstation of primary
care professionals, facilitating accessibility to the patient FS
historical report, as well as access to off-line remote support by
specialised professionals, upon request. A high-level description
of the proposed logical workﬂow is presented and described
(Supplementary Figure S1) in the online Supplementary Material.
Roadmap for deployment and methodologies for assessment
The current status of the FS program shows a rather
mature scenario.25 The deployment process will follow a PDSA
methodology24 including iterations with different stakeholders,
namely, primary care professionals (nurses, general practitioners),
specialised professionals in respiratory medicine (doctors, allied
health professionals), equipment manufacturers, information and
communication technologists and so on. Regional adoption of the
FS program is being stimulated by establishment of ﬁnancial
incentives to health-care providers to foster transfer of standar-
dised FS testing into the shared EHR at the regional level
(Supplementary Figure S1, steps 3 and 4). Moreover, the
deployment of the FS program is aligned with different innovation
initiatives implementing ICT-supported integrated care services
in Catalonia. Different pilot experiences22,23 have contributed
to identify four sequential milestones described in the online
Supplementary Material.
Capacity for generalisation to other diagnostic modalities
The protocol is expected to be the basis for future deployment
of collaborative programs for many other respiratory and
non-respiratory testing procedures. This is so, because the main
components of the FS-speciﬁc service workﬂow and supporting
health information systems are conceptually designed to be
extrapolated to collaborative scenarios wherein care coordination
and telehealth are key features facilitating efﬁcient transfer of
diagnostic tools from specialised and community care. For
example, the guide for standardisation of spirometry documents
(CDA) can be adapted to other diagnostic modalities (i.e.,
home-based sleep studies, electrocardiogram and so on) after
reaching consensus among key opinion leaders and scientiﬁc
societies for each speciﬁc diagnostics area.
Figure 1. Four pivotal components (circles with light-blue background) for regional deployment of the collaborative FS program across
health-care tiers. Dotted-line empty circles illustrate underlying health information systems.
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DATA ANALYTICS
The large number of standardised FS documents, including quality
certiﬁcation, stored into the system should open avenues
for privacy preserving data mining. For instance, longitudinal
evolution of lung function decline21,26 may constitute a key
element for enhanced clinical risk assessment and stratiﬁcation.
Moreover, analysis of variability could provide novel approaches
for assessment of bronchial hyper-responsiveness. Effects of
interventions on longitudinal evolution of lung function results
may provide new insights on efﬁcacy of clinical actions.
DISCUSSION
There is evidence that deployment of integrated care services for
chronic patients can generate health-care efﬁciencies22,27 that are
partly explained by the transfer of service complexities from
specialised care to the community. In this scenario, availability of
high-quality testing with a collaborative approach constitutes a
relevant component of the chronic care model that fosters
optimisation of health-care outcomes.
The current protocol shows the articulation of different
technological developments9,16–18 carried out and validated in
Catalonia during the last years in order to generate a collaborative
ecosystem for diagnostic purposes across health-care tiers having
FS testing as a use case. The research indicates that the Catalan FS
program has high potential for transferability to other geographi-
cal areas despite having different interoperability schemes, as well
as to other respiratory and non-respiratory testing procedures (see
online Supplementary Material). Speciﬁcally, the report describes
the strategy for scaling up the collaborative service at the regional
level. Moreover, the protocol generated a proposal for long-term
assessment of adoption of the FS program (Supplementary
Table S2), beyond the initial deployment phase.
Expected impact and future developments
Data analytics from the regional deployment of the collaborative
FS program may generate immediate positive impacts on several
areas, namely, (i) sustained increase of high-quality FS testing
in primary care; (ii) collaborative environment across health-care
tiers; (iii) enhanced professional development of health
professionals; (iv) better diagnostic ascertainment for respiratory
diseases; (v) reduction of unnecessary test duplication; and
(vi) facilitation of coordinated interactions with FS testing carried
out in the informal care scenario: that is, pharmacy ofﬁces for
COPD case-ﬁnding purposes and home-based FS testing in
selected patients (i.e., severe asthma refractory to treatment).4,5
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